TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Steris ( (STE) ) just unveiled an update.
On July 1, 2025, Dr. Richard Steeves announced his retirement from the Board of Directors of STERIS plc, effective at the company’s Annual General Meeting on July 31, 2025. Dr. Steeves’ retirement is amicable and not due to any disagreements with the company, and he is thanked for his decade of service.
The most recent analyst rating on (STE) stock is a Hold with a $263.00 price target. To see the full list of analyst forecasts on Steris stock, see the STE Stock Forecast page.
Spark’s Take on STE Stock
According to Spark, TipRanks’ AI Analyst, STE is a Outperform.
Steris is positioned strongly in the medical devices industry with commendable financial performance and positive earnings call highlights. The technical indicators support a bullish outlook, albeit with valuation concerns due to a high P/E ratio. Overall, the stock shows a favorable growth trajectory but with certain risks that warrant attention.
To see Spark’s full report on STE stock, click here.
More about Steris
Average Trading Volume: 652,284
Technical Sentiment Signal: Strong Buy
Current Market Cap: $23.87B
Find detailed analytics on STE stock on TipRanks’ Stock Analysis page.